| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥17.67 |
| 52 Week High | CN¥24.51 |
| 52 Week Low | CN¥4.53 |
| Beta | 0.18 |
| 11 Month Change | 8.74% |
| 3 Month Change | -6.01% |
| 1 Year Change | 279.18% |
| 33 Year Change | 269.67% |
| 5 Year Change | 159.85% |
| Change since IPO | 191.91% |
Recent News & Updates
Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) Seems To Use Debt Quite Sensibly
Jun 03
Should You Be Adding Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) To Your Watchlist Today?
May 12Recent updates
Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) Seems To Use Debt Quite Sensibly
Jun 03Should You Be Adding Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) To Your Watchlist Today?
May 12Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SZSE:000766) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected
Mar 06Shareholder Returns
| 766 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 2.3% | -3.7% | -1.6% |
| 1Y | 279.2% | -13.0% | -15.7% |
Return vs Industry: 000766 exceeded the CN Pharmaceuticals industry which returned -13% over the past year.
Return vs Market: 000766 exceeded the CN Market which returned -15.7% over the past year.
Price Volatility
| 766 volatility | |
|---|---|
| 766 Average Weekly Movement | 7.8% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.1% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 000766 has not had significant price volatility in the past 3 months.
Volatility Over Time: 000766's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 1,696 | Hongjun Zhan | www.thjm.cn |
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. engages in the research, development, manufacture, and sale of traditional Chinese medicine, Chinese and western raw materials, and biochemical preparations in China. The company offers traditional Chinese medicines, such as anticancer, gynecological, Rheumatic, osteopathy, urology, heat-clearing and detoxifying, cardiovascular, digestive, strengthening and tonic, respiratory, diabetes, senses, and pediatric medication products, as well as Western medicines.
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd Fundamentals Summary
| 766 fundamental statistics | |
|---|---|
| Market cap | CN¥17.08b |
| Earnings (TTM) | CN¥43.93m |
| Revenue (TTM) | CN¥1.47b |
388.7x
P/E Ratio11.6x
P/S RatioIs 766 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 766 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.47b |
| Cost of Revenue | CN¥379.14m |
| Gross Profit | CN¥1.09b |
| Other Expenses | CN¥1.05b |
| Earnings | CN¥43.93m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.045 |
| Gross Margin | 74.27% |
| Net Profit Margin | 2.98% |
| Debt/Equity Ratio | 73.4% |
How did 766 perform over the long term?
See historical performance and comparison